Ormat Technologies Completes $1 Billion Convertible Note Offering at Significant Premium

summarizeSummary

Ormat Technologies completed a $1.0 billion private offering of convertible senior notes with a conversion price significantly above the current stock price, using proceeds for debt repurchase, share buyback, and general corporate purposes.

check_boxKey Events

• Completed $1.0 Billion Convertible Note Offering

  Ormat Technologies completed a private offering of $825 million in 1.50% Series A Convertible Senior Notes and $175 million in 0.00% Series B Convertible Senior Notes, both due March 15, 2031, raising approximately $975.7 million in net proceeds.

• Premium Conversion Price

  The notes feature an initial conversion price of approximately $140.40 per share, representing a significant premium over the current stock price of $105.99, reflecting institutional confidence.

• Strategic Use of Proceeds

  Proceeds will be used to repurchase approximately $285.9 million of outstanding 2027 convertible notes, repurchase $25 million of common stock at $108.00 per share to offset dilution, and for general corporate purposes.

• Potential Future Dilution

  Up to 9,259,200 shares of common stock may be issued upon conversion of the notes, subject to customary anti-dilution adjustments.

auto_awesomeAnalysis

Ormat Technologies has completed a substantial $1.0 billion private offering of convertible senior notes, consisting of $825 million in Series A notes (1.50% interest) and $175 million in Series B notes (0.00% interest), both due 2031. This offering, which included the full exercise of initial purchasers' options, provides approximately $975.7 million in net proceeds. The initial conversion price of $140.40 per share represents a significant premium of approximately 32.5% over the current stock price of $105.99, indicating strong investor confidence. The company plans to use a portion of the proceeds to repurchase $285.9 million of its outstanding 2027 convertible notes and $25 million of its common stock at $108.00 per share, with the remainder allocated for general corporate purposes. This strategic financing strengthens the company's balance sheet by managing existing debt and securing capital for future operations, despite the potential for future dilution if the notes are converted.